[Prevention of venous thromboembolic events by fondaparinux 2.5mg in patients hospitalized for an acute medical illness. ArchiMed Study]
| Autor: | C, Leroyer, I, Mahé, J-P, Daurès, I, Quéré, C, Aubin, A, Compagnon, J, Doussaint, S, Schück, D, Pouchain |
|---|---|
| Přispěvatelé: | Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Recherche Clinique ville-hôpital, Méthodologies et Société (REMES), Université Paris Diderot - Paris 7 (UPD7), Hôpital Louis Mourier - AP-HP [Colombes], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Caractéristiques féminines des dysfonctions des interfaces cardio-vasculaires (EA 2992), Laboratoire GlaxoSmithKline [ Marly-le-Roi], Kappa, Université Francois Rabelais [Tours] |
| Jazyk: | francouzština |
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male Adolescent Epidemiology Hospital Departments Hemorrhage Body Mass Index Young Adult Postoperative Complications Polysaccharides Risk Factors Venous thrombosis Drug utilization Humans Thrombophilia Prospective Studies Thrombose veineuse Diagnosis-Related Groups Aged Aged 80 and over Anticoagulants Venous Thromboembolism Length of Stay Middle Aged Hospitalization Épidémiologie Fondaparinux Socioeconomic Factors Creatinine Acute Disease Practice Guidelines as Topic Female France Pharmacy Service Hospital Hôpital Bed Rest [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology Utilisation médicament |
| Zdroj: | Journal des Maladies Vasculaires Journal des Maladies Vasculaires, Elsevier Masson, 2015, 40 (4), pp.248-258. ⟨10.1016/j.jmv.2015.05.001⟩ |
| ISSN: | 0398-0499 |
| DOI: | 10.1016/j.jmv.2015.05.001⟩ |
| Popis: | International audience; OBJECTIVE:To evaluate the average duration of in-hospital treatment with fondaparinux 2.5mg prescribed for venous thromboprophylaxis in acutely ill medical patients and to describe the treatment population.METHODS:Prospective, observational, national, multicentre, epidemiological study, performed in France at the request of the Transparency Commission of the French National Health Authority (Haute Autorité de Santé). This is part of a larger study program that also included a study with similar design in the general practice setting. The hospital practice part of the study was conducted by hospital pharmacists who were asked to include the first 15 adult subjects hospitalized in a non-surgical ward for whom fondaparinux 2.5mg was initiated for prophylaxis.RESULTS:Fifty-three pharmacists (49.5%) included a total of 718 patients. The average age was 71 ± 16 years (47% |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect